Development of real time PCR assays for the quantification of Fas and FasL mRNA levels in lymphocytes: studies on centenarians

[1]  G. Salvioli,et al.  Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians , 2002, Cell Death and Differentiation.

[2]  Anne Eckert,et al.  Age-related impairment of human T lymphocytes’ activation: specific differences between CD4+ and CD8+ subsets , 2002, Mechanisms of Ageing and Development.

[3]  B. Herman,et al.  Ageing and apoptosis , 2002, Mechanisms of Ageing and Development.

[4]  Gaochao Zhou,et al.  27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.

[5]  C. Franceschi,et al.  Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians , 2001, Mechanisms of Ageing and Development.

[6]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[7]  D. Kaplan,et al.  Enzymatic amplification staining for flow cytometric analysis of cell surface molecules. , 2000, Cytometry.

[8]  C. Franceschi,et al.  Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. , 2000, Blood.

[9]  S. Nagata,et al.  Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection , 2000, AIDS.

[10]  S. Gupta,et al.  Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. , 2000, Vaccine.

[11]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[12]  G. Pawelec,et al.  Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes☆ , 1999, Experimental Gerontology.

[13]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[14]  D. Huhn,et al.  Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. , 1999, Clinical chemistry.

[15]  H. Lutz,et al.  One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses , 1999, Journal of Virological Methods.

[16]  M. Peter,et al.  Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.

[17]  D. Smith,et al.  Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. , 1998, Journal of immunology.

[18]  S. Aggarwal,et al.  Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. , 1998, Journal of immunology.

[19]  G. Pawelec,et al.  T cells and aging. , 1998, Frontiers in bioscience : a journal and virtual library.

[20]  C. Franceschi,et al.  Cytometric analysis of immunosenescence. , 1997, Cytometry.

[21]  V. Depraetere,et al.  Fas and other cell death signaling pathways. , 1997, Seminars in immunology.

[22]  M. Phelouzat,et al.  Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence , 1996, Mechanisms of Ageing and Development.

[23]  J. Campisi,et al.  Replicative Senescence: An Old Lives' Tale? , 1996, Cell.

[24]  F. Ramsdell,et al.  Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.

[25]  J. Mountz,et al.  Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. , 1995, The Biochemical journal.

[26]  E. Wang,et al.  Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. , 1995, Cancer research.

[27]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[28]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[29]  S. Ju,et al.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.

[30]  S. Cory.  Fascinating death factor , 1994, Nature.

[31]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.

[32]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[33]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[34]  J. D. Young,et al.  Cell Death Mechanisms and the Immune System , 1991, Immunological reviews.

[35]  R. Zinkernagel,et al.  T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens , 1988, Nature.

[36]  P. Marrack,et al.  A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex product , 1987, Cell.

[37]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[38]  C. Franceschi,et al.  The immunology of exceptional individuals: the lesson of centenarians. , 1995, Immunology today.

[39]  V. Fadok,et al.  Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.